Gene · 990
Papers3,285
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
781 to 800 of 3,285
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CDT1 Is a Novel Prognostic and Predictive Biomarkers for Hepatocellular Carcinoma. | Front Oncol | 2021 | 34631549 | PubTator, text mining | PubMed |
| Novel chemotherapeutic agent FX-9 activates NF-κB signaling and induces G1 phase arrest by activating CDKN1A in a human prostate cancer cell line. | BMC Cancer | 2021 | 34625047 | PubTator, text mining | PubMed |
| Acer mono Extract Inhibits Invasive Activities and G1/S Transition of HT1080 Fibrosarcoma Cells. | Chonnam Med J | 2021 | 34621638 | PubTator, text mining | PubMed |
| Whole-Exome Sequencing on Circulating Tumor Cells Explores Platinum-Drug Resistance Mutations in Advanced Non-small Cell Lung Cancer. | Front Genet | 2021 | 34616428 | PubTator, text mining | PubMed |
| Immunohistochemical evaluation of D2-40, Galectin-3, Maspin and MCM7 expression in palate squamous cell carcinomas. | Rom J Morphol Embryol | 2021 | 34609416 | PubTator, text mining | PubMed |
| SPOP mutation induces replication over-firing by impairing Geminin ubiquitination and triggers replication catastrophe upon ATR inhibition. | Nat Commun | 2021 | 34599168 | PubTator, text mining | PubMed |
| Identification of key genes in osteosarcoma - before and after CDK7 treatment. | Medicine (Baltimore) | 2021 | 34596127 | PubTator, text mining | PubMed |
| Identification of hub genes and candidate drugs in hepatocellular carcinoma by integrated bioinformatics analysis. | Medicine (Baltimore) | 2021 | 34596112 | PubTator, text mining | PubMed |
| Using BioPAX-Parser (BiP) to enrich lists of genes or proteins with pathway data. | BMC Bioinformatics | 2021 | 34592927 | PubTator, text mining | PubMed |
| Overexpression of cyclin-dependent kinase 1 in esophageal squamous cell carcinoma and its clinical significance. | FEBS Open Bio | 2021 | 34586751 | PubTator, text mining | PubMed |
| Precision Oncology with Drugs Targeting the Replication Stress, ATR, and Schlafen 11. | Cancers (Basel) | 2021 | 34572827 | PubTator, text mining | PubMed |
| Gene Signatures Induced by Ionizing Radiation as Prognostic Tools in an In Vitro Experimental Breast Cancer Model. | Cancers (Basel) | 2021 | 34572798 | PubTator, text mining | PubMed |
| A biallelic SNIP1 Amish founder variant causes a recognizable neurodevelopmental disorder. | PLoS Genet | 2021 | 34570759 | PubTator, text mining | PubMed |
| Can We Improve Antifungal Susceptibility Testing? | Front Cell Infect Microbiol | 2021 | 34568095 | PubTator, text mining | PubMed |
| Identification of a Gene Prognostic Model of Gastric Cancer Based on Analysis of Tumor Mutation Burden. | Pathol Oncol Res | 2021 | 34566519 | PubTator, text mining | PubMed |
| Integrative genomics analysis of nasal intestinal-type adenocarcinomas demonstrates the major role of CACNA1C and paves the way for a simple diagnostic tool in male woodworkers. | Clin Epigenetics | 2021 | 34563241 | PubTator, text mining | PubMed |
| CXCL10 and its related key genes as potential biomarkers for psoriasis: Evidence from bioinformatics and real-time quantitative polymerase chain reaction. | Medicine (Baltimore) | 2021 | 34559160 | PubTator, text mining | PubMed |
| Involvement of c-Myc in low dose radiation-induced senescence enhanced migration and invasion of unirradiated cancer cells. | Aging (Albany NY) | 2021 | 34552037 | PubTator, text mining | PubMed |
| [7SK truncation at 128-179 nt suppresses embryonic stem cell proliferation in vitro by downregulating CDC6]. | Nan Fang Yi Ke Da Xue Xue Bao | 2021 | 34549701 | PubTator, text mining | PubMed |
| Efficiency and equity in origin licensing to ensure complete DNA replication. | Biochem Soc Trans | 2021 | 34545932 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/990/papers?page=40